Epimmune Licenses Gene Delivery Technologies

Inc. has licensed Valentis, Inc.’s proprietary PINC gene delivery technology for Epimmune’s preventive and therapeutic DNA vaccines in development against the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV). Valentis has granted a non-exclusive license to certain patented and non-patented technology for use in developing DNA vaccines against HIV and HCV in exchange for undisclosed upfront, milestone and royalty payments.

“The licensing of Valentis’ delivery technology should help expedite the clinical development of our HIV and HCV programs,” said Robert Chesnut, Ph.D., Executive Vice President of Research and Development for Epimmune.

“Working together with Valentis, we have developed pre-clinical data demonstrating that one of the PINC formulations is very effective at delivering our EpiGene vaccines. We believe that access to this technology provides us with a proven means of delivering our epitope-based DNA vaccines.”

“This is the first license we have granted for our vaccine delivery technologies,” said Gregory M. McKee, Valentis’ Senior Director of Business Development.

“The collaboration with supports our strategy of leveraging our gene delivery and expression technology platforms across multiple product opportunities. DNA vaccines are an exciting new area and we are pleased that Epimmune chose our delivery and expression technologies for incorporation into their products.”

Valentis‘ formulated PINC polymer gene delivery technology licensed to produces a strong and reproducible humoral and cellular response in animal models.

PINC polymers are also being used in Valentis’ Interferon-alpha and Interleukin-12 gene medicines that are currently in Phase II clinical trials.

Inc. is a leader in using gene maps of cancer-associated proteins and infectious agents to design vaccines that induce cellular immunity.

The company’s extensive technology platform is based on its pioneering work in deciphering the genetic code which regulates T- cell activation and identifying antigen fragments known as epitopes which can activate highly targeted T-cell responses to tumours, viruses, bacteria and parasites.

Buy Dragon Pharmaceuticals Ready for Use

Nolvadex - Bulk Price

Administration: Oral
Basic Substance: Tamoxifen Citrate
Manufacturer: Dragon Pharma LLC
Amount: 10 x 100 pills (20 mg/pill)
Price: 10 x $40.00

Tritren 150

Injectable Anabolic Steroid
Active Component: Trenbolones Blend
Produced by: Dragon Pharma LLC
Amount: 1 X 10 ml (150 mg/ml)

Propionat 100 - Cheap Price

Administration: Injection
Main Substance: Testosterone Propionate
Branded by: Dragon Pharma LLC
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $25.00

Oxymetholon - Cheap Price

Administration: Oral
Basic Constituent: Oxymetholone
Produced by: Dragon Pharma LLC
Unit: 20 x 100 pastilles (50 mg/tab)
Price: 20 x $57.00

Dianabol

Natural Anabolic Steroidal Agent
Active Component: Methandrostenolone
Producer: Dragon Pharmaceuticals
Amount: 1 X 100 tablets (20 mg/pill)

Masteron 100

Injectable Steroid for Muscle Growth
Base Constituent: Drostanolone Di-Propionate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (100 mg/mL)

EQ 300

Injectable Steroid for Muscle Growth
Principal Constituent: Boldenone Undecylenate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (300 mg/mL)

Propionat 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Constituent: Testosterone Propionate
Produced by: Dragon Pharma
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total

EQ 200 / Test E 200

Basic Constituent: Boldenone Undecylenate, Testosterone Enanthate
Producer: Dragon Pharmaceuticals
Amount: 10 mL vial (400 mg/mL)

Sustanon 350

Basic Component: Testosterone Blend
Branded by: Dragon Pharmaceuticals
Pack: 10 x 10 mL vial (350 mg/mL)

Trenbolone 200

Prime Component: Trenbolone Enanthate
Made by: Dragon Pharmaceuticals
Pack: 10 mL vial (200 mg/mL)

Propionat 100

Base Substance: Testosterone Propionate
Branded by: Dragon Pharma LLC
Package: 10 x 10 mL vial (100 mg/mL)